BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering, recently merged with Streamex Exchange Corporation.
The Company plans to use the net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offering Details
Shares of common stock (or pre-funded warrants) will be offered through the underwritten public offering.
Use of Proceeds
The net proceeds will go towards purchasing gold bullion and supporting general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are the acting joint book-running managers.
- The completion of the offering is subject to market conditions with no guaranteed timing, size, or terms.
- Investors should carefully review the preliminary prospectus supplement and accompanying base prospectus for complete information before investing.
BioSig Technologies Inc.'s proposed public offering marks a strategic move to raise capital for specific purposes, emphasizing their commitment to long-term growth and financial stability.